286 related articles for article (PubMed ID: 24369590)
1. [Clinical evaluation of a newly developed high-sensitive detection of hepatitis B virus surface antigen by a semi-automated immune complex transfer chemiluminescent enzyme immunoassay].
Ohne K; Kani S; Ohashi M; Shinkai N; Inoue T; Wakimoto Y; Tanaka Y
Rinsho Byori; 2013 Sep; 61(9):787-94. PubMed ID: 24369590
[TBL] [Abstract][Full Text] [Related]
2. Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.
Shinkai N; Kusumoto S; Murakami S; Ogawa S; Ri M; Matsui T; Tamori A; Toyoda H; Ishida T; Iida S; Tanaka Y
Liver Int; 2017 Aug; 37(8):1138-1147. PubMed ID: 27992664
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.
Takeda K; Maruki M; Yamagaito T; Muramatsu M; Sakai Y; Tobimatsu H; Kobayashi H; Mizuno Y; Hamaguchi Y
J Clin Microbiol; 2013 Jul; 51(7):2238-44. PubMed ID: 23658266
[TBL] [Abstract][Full Text] [Related]
4. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
[TBL] [Abstract][Full Text] [Related]
5. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.
Yang L; Song LW; Fang LL; Wu Y; Ge SX; Li H; Yuan Q; Zhang J; Xia NS
J Virol Methods; 2016 Feb; 228():55-9. PubMed ID: 26615806
[TBL] [Abstract][Full Text] [Related]
7. Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.
Kusumoto S; Tanaka Y; Suzuki R; Watanabe T; Nakata M; Sakai R; Fukushima N; Fukushima T; Moriuchi Y; Itoh K; Nosaka K; Choi I; Sawa M; Okamoto R; Tsujimura H; Uchida T; Suzuki S; Okamoto M; Takahashi T; Sugiura I; Onishi Y; Kohri M; Yoshida S; Kojima M; Takahashi H; Tomita A; Atsuta Y; Maruyama D; Tanaka E; Suzuki T; Kinoshita T; Ogura M; Ueda R; Mizokami M
J Hepatol; 2020 Aug; 73(2):285-293. PubMed ID: 32194183
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
9. Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.
Shinkai N; Matsuura K; Sugauchi F; Watanabe T; Murakami S; Iio E; Ogawa S; Nojiri S; Joh T; Tanaka Y
J Clin Microbiol; 2013 Nov; 51(11):3484-91. PubMed ID: 23946517
[TBL] [Abstract][Full Text] [Related]
10. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
Ogata N
Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients].
Shinkai N; Tanaka Y; Matsuura K; Kani S; Naganuma H; Mizokami M
Rinsho Byori; 2010 Nov; 58(11):1078-84. PubMed ID: 21229705
[TBL] [Abstract][Full Text] [Related]
12. Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers.
Kohmoto M; Enomoto M; Tamori A; Habu D; Takeda T; Kawada N; Sakaguchi H; Seki S; Shiomi S; Nishiguchi S
J Med Virol; 2005 Feb; 75(2):235-9. PubMed ID: 15602726
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of a novel HBsAg quantitative assay].
Takagi K; Tanaka Y; Naganuma H; Hiramatsu K; Iida T; Takasaka Y; Mizokami M
Rinsho Byori; 2007 Jul; 55(7):619-25. PubMed ID: 17718057
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].
Sohn YH; Oh HB; Ko SY; Lim YS; Kwon OJ
Korean J Lab Med; 2009 Jun; 29(3):224-30. PubMed ID: 19571620
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.
Deguchi M; Kagita M; Yoshioka N; Tsukamoto H; Takao M; Tahara K; Maeda I; Hidaka Y; Yamauchi S; Kaneko A; Miyakoshi H; Isomura M
J Clin Lab Anal; 2018 May; 32(4):e22334. PubMed ID: 28984383
[TBL] [Abstract][Full Text] [Related]
17. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
Martin LA; Stramer SL; Kuhns MC; Schlauder GG
Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
[TBL] [Abstract][Full Text] [Related]
18. Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays.
Burdino E; Ruggiero T; Proietti A; Milia MG; Olivero A; Caviglia GP; Marietti M; Rizzetto M; Smedile A; Ghisetti V
J Clin Virol; 2014 Aug; 60(4):341-6. PubMed ID: 24930708
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.
Pancher M; Désiré N; Ngo Y; Akhavan S; Pallier C; Poynard T; Thibault V
J Clin Virol; 2015 Jan; 62():32-7. PubMed ID: 25542467
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of occult hepatitis B in HIV infected patients].
Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
